WHO updates clinical care guidance with corticosteroid recom
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
The World Health Organization (WHO) has released interim guidance, strongly recommending steroids to be used as a treatment for critically ill patients.

Amid the coronavirus pandemic, corticosteroids have received worldwide attention as a potentially effective COVID-19 treatment.

In June, preliminary results of the RECOVERY trial, published in a peer-reviewed paper showed that corticosteroids might help reduce the risk of death among patients with severe COVID-19.

The panel of health experts released two recommendations –

1. A strong recommendation for systemic (i.e. intravenous or oral) corticosteroid therapy (e.g. 6 mg of dexamethasone orally or intravenously daily or 50 mg of hydrocortisone intravenously every 8 hours) for 7 to 10 days in patients with severe and critical COVID-19

2. A conditional recommendation not to use corticosteroid therapy in patients with nonsevere COVID-19.

The WHO clarified that using corticosteroids in severely ill patients is recommended because if those with mild to moderate symptoms will use the drug, it will significantly deplete worldwide resources and deprive patients who may need the drug more.

Corticosteroids are a class of steroid hormones that lowers inflammation in the body as well as reduce the immune system’s activity.

Source: https://www.who.int/news-room/feature-stories/detail/who-updates-clinical-care-guidance-with-corticosteroid-recommendations
Dr. P●●●●●i R●j and 9 others like this7 shares
Like
Comment
Share